nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—Dimetacrine—Tamoxifen—pancreatic cancer	0.115	0.39	CrCrCtD
Chlorpromazine—Clofedanol—Tamoxifen—pancreatic cancer	0.0934	0.317	CrCrCtD
Chlorpromazine—Promazine—Tamoxifen—pancreatic cancer	0.0863	0.293	CrCrCtD
Chlorpromazine—ABCB11—Tamoxifen—pancreatic cancer	0.0687	0.16	CbGbCtD
Chlorpromazine—BCHE—Irinotecan—pancreatic cancer	0.0356	0.0827	CbGbCtD
Chlorpromazine—CYP2E1—Dacarbazine—pancreatic cancer	0.0293	0.068	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—pancreatic cancer	0.0288	0.0669	CbGbCtD
Chlorpromazine—KCNH2—Sunitinib—pancreatic cancer	0.0264	0.0614	CbGbCtD
Chlorpromazine—CYP2E1—Tamoxifen—pancreatic cancer	0.0233	0.0541	CbGbCtD
Chlorpromazine—ALB—Erlotinib—pancreatic cancer	0.0191	0.0445	CbGbCtD
Chlorpromazine—ALB—Irinotecan—pancreatic cancer	0.0173	0.0401	CbGbCtD
Chlorpromazine—CYP1A2—Dacarbazine—pancreatic cancer	0.0169	0.0393	CbGbCtD
Chlorpromazine—ALB—Fluorouracil—pancreatic cancer	0.0166	0.0385	CbGbCtD
Chlorpromazine—CYP1A2—Tamoxifen—pancreatic cancer	0.0135	0.0313	CbGbCtD
Chlorpromazine—ABCB1—Tamoxifen—pancreatic cancer	0.0118	0.0273	CbGbCtD
Chlorpromazine—ABCB11—bile duct—pancreatic cancer	0.0115	0.23	CbGeAlD
Chlorpromazine—CYP1A2—Erlotinib—pancreatic cancer	0.0114	0.0266	CbGbCtD
Chlorpromazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0111	0.0258	CbGbCtD
Chlorpromazine—ABCB1—Gemcitabine—pancreatic cancer	0.0101	0.0236	CbGbCtD
Chlorpromazine—ABCB1—Erlotinib—pancreatic cancer	0.01	0.0233	CbGbCtD
Chlorpromazine—CYP1A2—Fluorouracil—pancreatic cancer	0.00992	0.023	CbGbCtD
Chlorpromazine—CYP2D6—Erlotinib—pancreatic cancer	0.00943	0.0219	CbGbCtD
Chlorpromazine—ABCB1—Irinotecan—pancreatic cancer	0.00904	0.021	CbGbCtD
Chlorpromazine—ABCB11—bile—pancreatic cancer	0.00883	0.177	CbGeAlD
Chlorpromazine—HTR7—enteric nervous system—pancreatic cancer	0.00752	0.151	CbGeAlD
Chlorpromazine—CYP3A4—Tamoxifen—pancreatic cancer	0.00705	0.0164	CbGbCtD
Chlorpromazine—ABCB1—Docetaxel—pancreatic cancer	0.00663	0.0154	CbGbCtD
Chlorpromazine—ABCB1—Sunitinib—pancreatic cancer	0.0066	0.0153	CbGbCtD
Chlorpromazine—CYP3A4—Erlotinib—pancreatic cancer	0.006	0.0139	CbGbCtD
Chlorpromazine—CYP3A4—Irinotecan—pancreatic cancer	0.00542	0.0126	CbGbCtD
Chlorpromazine—ABCB1—Doxorubicin—pancreatic cancer	0.00494	0.0115	CbGbCtD
Chlorpromazine—HTR2A—enteric nervous system—pancreatic cancer	0.00469	0.0939	CbGeAlD
Chlorpromazine—CYP2D6—Doxorubicin—pancreatic cancer	0.00465	0.0108	CbGbCtD
Chlorpromazine—CYP3A4—Docetaxel—pancreatic cancer	0.00397	0.00922	CbGbCtD
Chlorpromazine—CYP3A4—Sunitinib—pancreatic cancer	0.00395	0.00918	CbGbCtD
Chlorpromazine—Megacolon—Irinotecan—pancreatic cancer	0.00375	0.0474	CcSEcCtD
Chlorpromazine—CYP3A4—Doxorubicin—pancreatic cancer	0.00296	0.00687	CbGbCtD
Chlorpromazine—Retinal disorder—Tamoxifen—pancreatic cancer	0.00244	0.0309	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Sunitinib—pancreatic cancer	0.00224	0.0283	CcSEcCtD
Chlorpromazine—SMPD1—islet of Langerhans—pancreatic cancer	0.00203	0.0406	CbGeAlD
Chlorpromazine—Priapism—Tamoxifen—pancreatic cancer	0.00181	0.0228	CcSEcCtD
Chlorpromazine—Miosis—Irinotecan—pancreatic cancer	0.00147	0.0186	CcSEcCtD
Chlorpromazine—Sudden death—Sunitinib—pancreatic cancer	0.00146	0.0185	CcSEcCtD
Chlorpromazine—ALB—gall bladder—pancreatic cancer	0.00133	0.0266	CbGeAlD
Chlorpromazine—Parkinsonism—Fluorouracil—pancreatic cancer	0.0013	0.0164	CcSEcCtD
Chlorpromazine—SMPD1—digestive system—pancreatic cancer	0.00122	0.0244	CbGeAlD
Chlorpromazine—Sudden death—Irinotecan—pancreatic cancer	0.0012	0.0152	CcSEcCtD
Chlorpromazine—Sudden death—Fluorouracil—pancreatic cancer	0.00115	0.0146	CcSEcCtD
Chlorpromazine—CALM2—gall bladder—pancreatic cancer	0.00113	0.0226	CbGeAlD
Chlorpromazine—Akathisia—Irinotecan—pancreatic cancer	0.00111	0.0141	CcSEcCtD
Chlorpromazine—Amenorrhoea—Tamoxifen—pancreatic cancer	0.000994	0.0126	CcSEcCtD
Chlorpromazine—ABCB11—digestive system—pancreatic cancer	0.000964	0.0193	CbGeAlD
Chlorpromazine—CALM3—islet of Langerhans—pancreatic cancer	0.000941	0.0188	CbGeAlD
Chlorpromazine—Endocrine disorder—Sunitinib—pancreatic cancer	0.000902	0.0114	CcSEcCtD
Chlorpromazine—Blood disorder—Sunitinib—pancreatic cancer	0.000895	0.0113	CcSEcCtD
Chlorpromazine—Gait disturbance—Tamoxifen—pancreatic cancer	0.000895	0.0113	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Epirubicin—pancreatic cancer	0.00086	0.0109	CcSEcCtD
Chlorpromazine—Oropharyngeal pain—Sunitinib—pancreatic cancer	0.000822	0.0104	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Doxorubicin—pancreatic cancer	0.000796	0.0101	CcSEcCtD
Chlorpromazine—Systemic lupus erythematosus—Docetaxel—pancreatic cancer	0.000769	0.00971	CcSEcCtD
Chlorpromazine—CALM2—islet of Langerhans—pancreatic cancer	0.000739	0.0148	CbGeAlD
Chlorpromazine—CALM1—islet of Langerhans—pancreatic cancer	0.000736	0.0147	CbGeAlD
Chlorpromazine—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.000695	0.00877	CcSEcCtD
Chlorpromazine—KCNH2—islet of Langerhans—pancreatic cancer	0.00067	0.0134	CbGeAlD
Chlorpromazine—CALM3—pancreas—pancreatic cancer	0.000662	0.0132	CbGeAlD
Chlorpromazine—Gait disturbance—Irinotecan—pancreatic cancer	0.000631	0.00797	CcSEcCtD
Chlorpromazine—Nasal congestion—Sunitinib—pancreatic cancer	0.000596	0.00753	CcSEcCtD
Chlorpromazine—Throat sore—Docetaxel—pancreatic cancer	0.000591	0.00746	CcSEcCtD
Chlorpromazine—Oropharyngeal discomfort—Docetaxel—pancreatic cancer	0.000585	0.0074	CcSEcCtD
Chlorpromazine—Dermatitis contact—Fluorouracil—pancreatic cancer	0.000583	0.00736	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Sunitinib—pancreatic cancer	0.000556	0.00703	CcSEcCtD
Chlorpromazine—Influenza—Tamoxifen—pancreatic cancer	0.000548	0.00692	CcSEcCtD
Chlorpromazine—Dysphagia—Tamoxifen—pancreatic cancer	0.000548	0.00692	CcSEcCtD
Chlorpromazine—Dysphagia—Erlotinib—pancreatic cancer	0.000542	0.00685	CcSEcCtD
Chlorpromazine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000527	0.0106	CbGeAlD
Chlorpromazine—Pancytopenia—Tamoxifen—pancreatic cancer	0.00052	0.00657	CcSEcCtD
Chlorpromazine—CALM2—pancreas—pancreatic cancer	0.00052	0.0104	CbGeAlD
Chlorpromazine—CALM1—pancreas—pancreatic cancer	0.000517	0.0104	CbGeAlD
Chlorpromazine—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.000504	0.00637	CcSEcCtD
Chlorpromazine—HTR2B—digestive system—pancreatic cancer	0.000504	0.0101	CbGeAlD
Chlorpromazine—Photosensitivity—Fluorouracil—pancreatic cancer	0.000488	0.00616	CcSEcCtD
Chlorpromazine—Amenorrhoea—Docetaxel—pancreatic cancer	0.000485	0.00612	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.000474	0.00599	CcSEcCtD
Chlorpromazine—Dysphagia—Sunitinib—pancreatic cancer	0.000469	0.00593	CcSEcCtD
Chlorpromazine—Oropharyngeal pain—Docetaxel—pancreatic cancer	0.000468	0.00591	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.000462	0.00584	CcSEcCtD
Chlorpromazine—CHRM3—digestive system—pancreatic cancer	0.000453	0.00908	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00045	0.00568	CcSEcCtD
Chlorpromazine—Pancytopenia—Sunitinib—pancreatic cancer	0.000446	0.00563	CcSEcCtD
Chlorpromazine—CALM2—digestive system—pancreatic cancer	0.000444	0.00889	CbGeAlD
Chlorpromazine—CALM1—digestive system—pancreatic cancer	0.000442	0.00884	CbGeAlD
Chlorpromazine—Oedema peripheral—Tamoxifen—pancreatic cancer	0.000432	0.00546	CcSEcCtD
Chlorpromazine—HTR7—digestive system—pancreatic cancer	0.000432	0.00864	CbGeAlD
Chlorpromazine—Cardiac arrest—Irinotecan—pancreatic cancer	0.000425	0.00537	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Sunitinib—pancreatic cancer	0.000423	0.00535	CcSEcCtD
Chlorpromazine—Visual impairment—Tamoxifen—pancreatic cancer	0.000423	0.00534	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.000408	0.00516	CcSEcCtD
Chlorpromazine—Cardiac arrest—Fluorouracil—pancreatic cancer	0.000407	0.00514	CcSEcCtD
Chlorpromazine—Influenza—Gemcitabine—pancreatic cancer	0.000376	0.00475	CcSEcCtD
Chlorpromazine—ADRA2A—pancreas—pancreatic cancer	0.000371	0.00742	CbGeAlD
Chlorpromazine—Dysphagia—Fluorouracil—pancreatic cancer	0.00037	0.00468	CcSEcCtD
Chlorpromazine—BCHE—digestive system—pancreatic cancer	0.00037	0.00741	CbGeAlD
Chlorpromazine—Oedema peripheral—Sunitinib—pancreatic cancer	0.00037	0.00467	CcSEcCtD
Chlorpromazine—Muscle spasms—Tamoxifen—pancreatic cancer	0.000367	0.00463	CcSEcCtD
Chlorpromazine—Eosinophilia—Fluorouracil—pancreatic cancer	0.000366	0.00463	CcSEcCtD
Chlorpromazine—Pancytopenia—Gemcitabine—pancreatic cancer	0.000357	0.00452	CcSEcCtD
Chlorpromazine—Glycosuria—Epirubicin—pancreatic cancer	0.000354	0.00448	CcSEcCtD
Chlorpromazine—Pancytopenia—Fluorouracil—pancreatic cancer	0.000351	0.00444	CcSEcCtD
Chlorpromazine—Angioedema—Tamoxifen—pancreatic cancer	0.000349	0.00441	CcSEcCtD
Chlorpromazine—CYP1A2—digestive system—pancreatic cancer	0.000344	0.00689	CbGeAlD
Chlorpromazine—Blood disorder—Epirubicin—pancreatic cancer	0.000344	0.00434	CcSEcCtD
Chlorpromazine—Leukopenia—Tamoxifen—pancreatic cancer	0.000342	0.00432	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00034	0.00429	CcSEcCtD
Chlorpromazine—Syncope—Erlotinib—pancreatic cancer	0.000339	0.00428	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000338	0.00427	CcSEcCtD
Chlorpromazine—Jaundice—Irinotecan—pancreatic cancer	0.000336	0.00424	CcSEcCtD
Chlorpromazine—Cough—Tamoxifen—pancreatic cancer	0.000333	0.00421	CcSEcCtD
Chlorpromazine—Loss of consciousness—Erlotinib—pancreatic cancer	0.000332	0.00419	CcSEcCtD
Chlorpromazine—Cough—Erlotinib—pancreatic cancer	0.00033	0.00416	CcSEcCtD
Chlorpromazine—Glycosuria—Doxorubicin—pancreatic cancer	0.000328	0.00414	CcSEcCtD
Chlorpromazine—Amenorrhoea—Epirubicin—pancreatic cancer	0.000327	0.00413	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.000327	0.00413	CcSEcCtD
Chlorpromazine—HRH1—digestive system—pancreatic cancer	0.000322	0.00645	CbGeAlD
Chlorpromazine—Blood disorder—Doxorubicin—pancreatic cancer	0.000318	0.00402	CcSEcCtD
Chlorpromazine—Dry mouth—Tamoxifen—pancreatic cancer	0.000318	0.00401	CcSEcCtD
Chlorpromazine—Muscle spasms—Sunitinib—pancreatic cancer	0.000314	0.00397	CcSEcCtD
Chlorpromazine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000313	0.00396	CcSEcCtD
Chlorpromazine—CYP2E1—digestive system—pancreatic cancer	0.00031	0.0062	CbGeAlD
Chlorpromazine—Infection—Tamoxifen—pancreatic cancer	0.000309	0.00391	CcSEcCtD
Chlorpromazine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000308	0.00389	CcSEcCtD
Chlorpromazine—Infection—Erlotinib—pancreatic cancer	0.000306	0.00387	CcSEcCtD
Chlorpromazine—Dyskinesia—Epirubicin—pancreatic cancer	0.000306	0.00386	CcSEcCtD
Chlorpromazine—Shock—Erlotinib—pancreatic cancer	0.000303	0.00383	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.000302	0.00382	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—pancreatic cancer	0.000302	0.00382	CcSEcCtD
Chlorpromazine—Angioedema—Sunitinib—pancreatic cancer	0.000299	0.00377	CcSEcCtD
Chlorpromazine—Visual impairment—Irinotecan—pancreatic cancer	0.000298	0.00377	CcSEcCtD
Chlorpromazine—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000297	0.00375	CcSEcCtD
Chlorpromazine—Gait disturbance—Epirubicin—pancreatic cancer	0.000294	0.00372	CcSEcCtD
Chlorpromazine—ABCB1—islet of Langerhans—pancreatic cancer	0.000294	0.00588	CbGeAlD
Chlorpromazine—Leukopenia—Sunitinib—pancreatic cancer	0.000293	0.0037	CcSEcCtD
Chlorpromazine—Cough—Sunitinib—pancreatic cancer	0.000285	0.0036	CcSEcCtD
Chlorpromazine—Dermatitis contact—Epirubicin—pancreatic cancer	0.000284	0.00359	CcSEcCtD
Chlorpromazine—Convulsion—Sunitinib—pancreatic cancer	0.000283	0.00358	CcSEcCtD
Chlorpromazine—Dyskinesia—Doxorubicin—pancreatic cancer	0.000283	0.00357	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000282	0.00357	CcSEcCtD
Chlorpromazine—Insomnia—Tamoxifen—pancreatic cancer	0.000282	0.00356	CcSEcCtD
Chlorpromazine—Insomnia—Erlotinib—pancreatic cancer	0.000279	0.00352	CcSEcCtD
Chlorpromazine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000278	0.00351	CcSEcCtD
Chlorpromazine—Dyspnoea—Erlotinib—pancreatic cancer	0.000275	0.00347	CcSEcCtD
Chlorpromazine—Gait disturbance—Doxorubicin—pancreatic cancer	0.000272	0.00344	CcSEcCtD
Chlorpromazine—Dry mouth—Sunitinib—pancreatic cancer	0.000272	0.00344	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00027	0.00341	CcSEcCtD
Chlorpromazine—HTR2A—digestive system—pancreatic cancer	0.000269	0.00539	CbGeAlD
Chlorpromazine—Dysphagia—Docetaxel—pancreatic cancer	0.000267	0.00337	CcSEcCtD
Chlorpromazine—Constipation—Tamoxifen—pancreatic cancer	0.000266	0.00336	CcSEcCtD
Chlorpromazine—Infection—Sunitinib—pancreatic cancer	0.000265	0.00335	CcSEcCtD
Chlorpromazine—Constipation—Erlotinib—pancreatic cancer	0.000264	0.00333	CcSEcCtD
Chlorpromazine—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000263	0.00332	CcSEcCtD
Chlorpromazine—Shock—Sunitinib—pancreatic cancer	0.000262	0.00332	CcSEcCtD
Chlorpromazine—Muscle spasms—Irinotecan—pancreatic cancer	0.000259	0.00327	CcSEcCtD
Chlorpromazine—Pancytopenia—Docetaxel—pancreatic cancer	0.000254	0.0032	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000249	0.00315	CcSEcCtD
Chlorpromazine—CYP3A4—digestive system—pancreatic cancer	0.000249	0.00499	CbGeAlD
Chlorpromazine—CYP2D6—digestive system—pancreatic cancer	0.000245	0.00491	CbGeAlD
Chlorpromazine—Body temperature increased—Erlotinib—pancreatic cancer	0.000244	0.00308	CcSEcCtD
Chlorpromazine—Syncope—Irinotecan—pancreatic cancer	0.000241	0.00305	CcSEcCtD
Chlorpromazine—Insomnia—Sunitinib—pancreatic cancer	0.000241	0.00305	CcSEcCtD
Chlorpromazine—Leukopenia—Irinotecan—pancreatic cancer	0.000241	0.00304	CcSEcCtD
Chlorpromazine—Dyspnoea—Sunitinib—pancreatic cancer	0.000238	0.003	CcSEcCtD
Chlorpromazine—Photosensitivity—Epirubicin—pancreatic cancer	0.000237	0.003	CcSEcCtD
Chlorpromazine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000237	0.00299	CcSEcCtD
Chlorpromazine—Cough—Irinotecan—pancreatic cancer	0.000235	0.00297	CcSEcCtD
Chlorpromazine—Leukopenia—Gemcitabine—pancreatic cancer	0.000235	0.00297	CcSEcCtD
Chlorpromazine—Jaundice—Docetaxel—pancreatic cancer	0.000232	0.00293	CcSEcCtD
Chlorpromazine—Leukopenia—Fluorouracil—pancreatic cancer	0.000231	0.00292	CcSEcCtD
Chlorpromazine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000229	0.0029	CcSEcCtD
Chlorpromazine—Cough—Gemcitabine—pancreatic cancer	0.000229	0.00289	CcSEcCtD
Chlorpromazine—Constipation—Sunitinib—pancreatic cancer	0.000228	0.00288	CcSEcCtD
Chlorpromazine—Convulsion—Fluorouracil—pancreatic cancer	0.000223	0.00282	CcSEcCtD
Chlorpromazine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000222	0.00281	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000221	0.00279	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00022	0.00278	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—pancreatic cancer	0.00022	0.00277	CcSEcCtD
Chlorpromazine—Infection—Irinotecan—pancreatic cancer	0.000218	0.00276	CcSEcCtD
Chlorpromazine—Shock—Irinotecan—pancreatic cancer	0.000216	0.00273	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000215	0.00272	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000214	0.0027	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000214	0.0027	CcSEcCtD
Chlorpromazine—Infection—Gemcitabine—pancreatic cancer	0.000213	0.00269	CcSEcCtD
Chlorpromazine—Body temperature increased—Sunitinib—pancreatic cancer	0.000211	0.00266	CcSEcCtD
Chlorpromazine—Oedema peripheral—Docetaxel—pancreatic cancer	0.000211	0.00266	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00021	0.00266	CcSEcCtD
Chlorpromazine—Infection—Fluorouracil—pancreatic cancer	0.000209	0.00264	CcSEcCtD
Chlorpromazine—ABCB1—pancreas—pancreatic cancer	0.000206	0.00413	CbGeAlD
Chlorpromazine—Visual impairment—Docetaxel—pancreatic cancer	0.000206	0.0026	CcSEcCtD
Chlorpromazine—Dizziness—Tamoxifen—pancreatic cancer	0.000206	0.0026	CcSEcCtD
Chlorpromazine—Tachycardia—Fluorouracil—pancreatic cancer	0.000205	0.00259	CcSEcCtD
Chlorpromazine—Hypotension—Irinotecan—pancreatic cancer	0.000205	0.00259	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000204	0.00258	CcSEcCtD
Chlorpromazine—Dizziness—Erlotinib—pancreatic cancer	0.000204	0.00257	CcSEcCtD
Chlorpromazine—Hypotension—Gemcitabine—pancreatic cancer	0.0002	0.00253	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000199	0.00252	CcSEcCtD
Chlorpromazine—Insomnia—Irinotecan—pancreatic cancer	0.000199	0.00251	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000198	0.0025	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000198	0.0025	CcSEcCtD
Chlorpromazine—Hypotension—Fluorouracil—pancreatic cancer	0.000197	0.00248	CcSEcCtD
Chlorpromazine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000197	0.00248	CcSEcCtD
Chlorpromazine—Dyspnoea—Irinotecan—pancreatic cancer	0.000196	0.00247	CcSEcCtD
Chlorpromazine—Somnolence—Irinotecan—pancreatic cancer	0.000195	0.00247	CcSEcCtD
Chlorpromazine—Insomnia—Gemcitabine—pancreatic cancer	0.000194	0.00245	CcSEcCtD
Chlorpromazine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000191	0.00241	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00019	0.00241	CcSEcCtD
Chlorpromazine—Insomnia—Fluorouracil—pancreatic cancer	0.00019	0.0024	CcSEcCtD
Chlorpromazine—Somnolence—Gemcitabine—pancreatic cancer	0.00019	0.0024	CcSEcCtD
Chlorpromazine—Constipation—Irinotecan—pancreatic cancer	0.000188	0.00237	CcSEcCtD
Chlorpromazine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000188	0.00237	CcSEcCtD
Chlorpromazine—Somnolence—Fluorouracil—pancreatic cancer	0.000187	0.00236	CcSEcCtD
Chlorpromazine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000183	0.00232	CcSEcCtD
Chlorpromazine—Constipation—Gemcitabine—pancreatic cancer	0.000183	0.00231	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—pancreatic cancer	0.00018	0.00228	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—pancreatic cancer	0.00018	0.00228	CcSEcCtD
Chlorpromazine—Dysphagia—Epirubicin—pancreatic cancer	0.00018	0.00228	CcSEcCtD
Chlorpromazine—Muscle spasms—Docetaxel—pancreatic cancer	0.000179	0.00226	CcSEcCtD
Chlorpromazine—Eosinophilia—Epirubicin—pancreatic cancer	0.000178	0.00225	CcSEcCtD
Chlorpromazine—Dizziness—Sunitinib—pancreatic cancer	0.000176	0.00223	CcSEcCtD
Chlorpromazine—ABCB1—digestive system—pancreatic cancer	0.000176	0.00353	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000176	0.00223	CcSEcCtD
Chlorpromazine—Body temperature increased—Irinotecan—pancreatic cancer	0.000174	0.00219	CcSEcCtD
Chlorpromazine—Pancytopenia—Epirubicin—pancreatic cancer	0.000171	0.00216	CcSEcCtD
Chlorpromazine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000169	0.00214	CcSEcCtD
Chlorpromazine—Syncope—Docetaxel—pancreatic cancer	0.000167	0.00211	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—pancreatic cancer	0.000167	0.00211	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—pancreatic cancer	0.000167	0.00211	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—pancreatic cancer	0.000167	0.00211	CcSEcCtD
Chlorpromazine—Leukopenia—Docetaxel—pancreatic cancer	0.000167	0.0021	CcSEcCtD
Chlorpromazine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000166	0.0021	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000165	0.00209	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000164	0.00208	CcSEcCtD
Chlorpromazine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000164	0.00207	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000163	0.00205	CcSEcCtD
Chlorpromazine—Cough—Docetaxel—pancreatic cancer	0.000162	0.00205	CcSEcCtD
Chlorpromazine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000162	0.00205	CcSEcCtD
Chlorpromazine—Convulsion—Docetaxel—pancreatic cancer	0.000161	0.00204	CcSEcCtD
Chlorpromazine—Drowsiness—Epirubicin—pancreatic cancer	0.000161	0.00203	CcSEcCtD
Chlorpromazine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000158	0.002	CcSEcCtD
Chlorpromazine—Jaundice—Epirubicin—pancreatic cancer	0.000157	0.00198	CcSEcCtD
Chlorpromazine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000155	0.00196	CcSEcCtD
Chlorpromazine—Dry mouth—Docetaxel—pancreatic cancer	0.000155	0.00196	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000152	0.00192	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000152	0.00192	CcSEcCtD
Chlorpromazine—Infection—Docetaxel—pancreatic cancer	0.000151	0.00191	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00015	0.0019	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—pancreatic cancer	0.00015	0.00189	CcSEcCtD
Chlorpromazine—Shock—Docetaxel—pancreatic cancer	0.000149	0.00189	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000149	0.00188	CcSEcCtD
Chlorpromazine—Tachycardia—Docetaxel—pancreatic cancer	0.000148	0.00187	CcSEcCtD
Chlorpromazine—Dizziness—Irinotecan—pancreatic cancer	0.000145	0.00184	CcSEcCtD
Chlorpromazine—Jaundice—Doxorubicin—pancreatic cancer	0.000145	0.00183	CcSEcCtD
Chlorpromazine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000142	0.00179	CcSEcCtD
Chlorpromazine—Hypotension—Docetaxel—pancreatic cancer	0.000142	0.00179	CcSEcCtD
Chlorpromazine—Dizziness—Fluorouracil—pancreatic cancer	0.000139	0.00176	CcSEcCtD
Chlorpromazine—Visual impairment—Epirubicin—pancreatic cancer	0.000139	0.00176	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000139	0.00175	CcSEcCtD
Chlorpromazine—Insomnia—Docetaxel—pancreatic cancer	0.000137	0.00174	CcSEcCtD
Chlorpromazine—Dyspnoea—Docetaxel—pancreatic cancer	0.000135	0.00171	CcSEcCtD
Chlorpromazine—Somnolence—Docetaxel—pancreatic cancer	0.000135	0.00171	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000131	0.00166	CcSEcCtD
Chlorpromazine—Constipation—Docetaxel—pancreatic cancer	0.00013	0.00164	CcSEcCtD
Chlorpromazine—Visual impairment—Doxorubicin—pancreatic cancer	0.000129	0.00162	CcSEcCtD
Chlorpromazine—Nervousness—Epirubicin—pancreatic cancer	0.000122	0.00154	CcSEcCtD
Chlorpromazine—Muscle spasms—Epirubicin—pancreatic cancer	0.000121	0.00152	CcSEcCtD
Chlorpromazine—Body temperature increased—Docetaxel—pancreatic cancer	0.00012	0.00152	CcSEcCtD
Chlorpromazine—Nervousness—Doxorubicin—pancreatic cancer	0.000113	0.00143	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—pancreatic cancer	0.000113	0.00142	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—pancreatic cancer	0.000112	0.00142	CcSEcCtD
Chlorpromazine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000112	0.00141	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000112	0.00141	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00011	0.00139	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—pancreatic cancer	0.00011	0.00138	CcSEcCtD
Chlorpromazine—Convulsion—Epirubicin—pancreatic cancer	0.000109	0.00137	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—pancreatic cancer	0.000105	0.00132	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—pancreatic cancer	0.000104	0.00132	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—pancreatic cancer	0.000104	0.00131	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000102	0.00129	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000102	0.00129	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—pancreatic cancer	0.000102	0.00129	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—pancreatic cancer	0.000101	0.00128	CcSEcCtD
Chlorpromazine—Shock—Epirubicin—pancreatic cancer	0.000101	0.00127	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—pancreatic cancer	0.000101	0.00127	CcSEcCtD
Chlorpromazine—Dizziness—Docetaxel—pancreatic cancer	0.0001	0.00127	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—pancreatic cancer	0.0001	0.00126	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—pancreatic cancer	9.67e-05	0.00122	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—pancreatic cancer	9.57e-05	0.00121	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.48e-05	0.0012	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—pancreatic cancer	9.42e-05	0.00119	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—pancreatic cancer	9.33e-05	0.00118	CcSEcCtD
Chlorpromazine—Insomnia—Epirubicin—pancreatic cancer	9.27e-05	0.00117	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—pancreatic cancer	9.25e-05	0.00117	CcSEcCtD
Chlorpromazine—Dyspnoea—Epirubicin—pancreatic cancer	9.13e-05	0.00115	CcSEcCtD
Chlorpromazine—Somnolence—Epirubicin—pancreatic cancer	9.11e-05	0.00115	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—pancreatic cancer	8.86e-05	0.00112	CcSEcCtD
Chlorpromazine—Constipation—Epirubicin—pancreatic cancer	8.76e-05	0.00111	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—pancreatic cancer	8.57e-05	0.00108	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—pancreatic cancer	8.45e-05	0.00107	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—pancreatic cancer	8.43e-05	0.00106	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—pancreatic cancer	8.11e-05	0.00102	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—pancreatic cancer	8.1e-05	0.00102	CcSEcCtD
Chlorpromazine—Hypersensitivity—Epirubicin—pancreatic cancer	7.55e-05	0.000954	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—pancreatic cancer	7.49e-05	0.000947	CcSEcCtD
Chlorpromazine—Hypersensitivity—Doxorubicin—pancreatic cancer	6.98e-05	0.000882	CcSEcCtD
Chlorpromazine—Dizziness—Epirubicin—pancreatic cancer	6.78e-05	0.000856	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—pancreatic cancer	6.27e-05	0.000792	CcSEcCtD
Chlorpromazine—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	2.22e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	2.21e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	2.21e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—pancreatic cancer	2.2e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	2.2e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	2.2e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	2.2e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	2.2e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	2.19e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.19e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KRAS—pancreatic cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—pancreatic cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—PIK3CA—pancreatic cancer	2.17e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	2.17e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	2.17e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	2.16e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	2.16e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	2.16e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.16e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	2.15e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	2.15e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	2.15e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	2.14e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	2.14e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	2.14e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	2.14e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	2.14e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	2.13e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	2.13e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—pancreatic cancer	2.13e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	2.13e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	2.13e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	2.13e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	2.13e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.13e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	2.13e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	2.12e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	2.12e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	2.12e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CASP3—pancreatic cancer	2.12e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KRAS—pancreatic cancer	2.11e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KRAS—pancreatic cancer	2.11e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	2.11e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	2.11e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PIK3CA—pancreatic cancer	2.1e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PIK3CA—pancreatic cancer	2.1e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	2.1e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	2.1e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.1e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	2.1e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	2.08e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.07e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	2.07e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—pancreatic cancer	2.06e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTEN—pancreatic cancer	2.06e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CASP3—pancreatic cancer	2.05e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CASP3—pancreatic cancer	2.05e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	2.04e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	2.03e-06	1.4e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	2.03e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	2.02e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	2.02e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—pancreatic cancer	2.01e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	2.01e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PIK3CA—pancreatic cancer	2.01e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—pancreatic cancer	2e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—pancreatic cancer	2e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—pancreatic cancer	2e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	1.99e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTEN—pancreatic cancer	1.99e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MYC—pancreatic cancer	1.99e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	1.99e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	1.99e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	1.98e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1.98e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.98e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	1.98e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.98e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.98e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	1.97e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	1.97e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.97e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.97e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.96e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.96e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—pancreatic cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	1.94e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PIK3CA—pancreatic cancer	1.94e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PIK3CA—pancreatic cancer	1.94e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	1.94e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—pancreatic cancer	1.94e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—pancreatic cancer	1.94e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	1.93e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTEN—pancreatic cancer	1.93e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTEN—pancreatic cancer	1.93e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.92e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.91e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.91e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	1.9e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	1.89e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	1.88e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	1.88e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	1.87e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.87e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	1.86e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.86e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—pancreatic cancer	1.86e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—SRC—pancreatic cancer	1.85e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	1.84e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	1.84e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	1.84e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	1.84e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	1.83e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	1.83e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	1.81e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	1.81e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.81e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.81e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.81e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	1.81e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.8e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	1.8e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	1.8e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—pancreatic cancer	1.8e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—pancreatic cancer	1.8e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—SRC—pancreatic cancer	1.79e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—SRC—pancreatic cancer	1.79e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—STAT3—pancreatic cancer	1.78e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NRAS—pancreatic cancer	1.78e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—pancreatic cancer	1.78e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—pancreatic cancer	1.78e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	1.77e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	1.74e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	1.74e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	1.73e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—STAT3—pancreatic cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—STAT3—pancreatic cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NRAS—pancreatic cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NRAS—pancreatic cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—pancreatic cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—pancreatic cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.7e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.69e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.69e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	1.69e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.68e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PIK3CA—pancreatic cancer	1.68e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.68e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.68e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	1.68e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.67e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	1.66e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.66e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.66e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MYC—pancreatic cancer	1.66e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.65e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	1.65e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—pancreatic cancer	1.64e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—pancreatic cancer	1.64e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	1.64e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—pancreatic cancer	1.63e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	1.63e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PIK3CA—pancreatic cancer	1.63e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PIK3CA—pancreatic cancer	1.63e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	1.62e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.62e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EGFR—pancreatic cancer	1.62e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.61e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MYC—pancreatic cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MYC—pancreatic cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	1.59e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	1.59e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—pancreatic cancer	1.59e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—pancreatic cancer	1.59e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EGFR—pancreatic cancer	1.57e-06	1.08e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EGFR—pancreatic cancer	1.57e-06	1.08e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	1.57e-06	1.08e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	1.56e-06	1.07e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	1.56e-06	1.07e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	1.55e-06	1.07e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.54e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.54e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.53e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KRAS—pancreatic cancer	1.53e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	1.52e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—pancreatic cancer	1.5e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	1.49e-06	1.02e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KRAS—pancreatic cancer	1.48e-06	1.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KRAS—pancreatic cancer	1.48e-06	1.02e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.48e-06	1.02e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PIK3CA—pancreatic cancer	1.45e-06	9.99e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.44e-06	9.91e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	1.43e-06	9.8e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	1.41e-06	9.66e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.41e-06	9.66e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	1.38e-06	9.51e-06	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.38e-06	9.5e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	1.38e-06	9.49e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.38e-06	9.46e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—pancreatic cancer	1.37e-06	9.44e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.37e-06	9.43e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—pancreatic cancer	1.36e-06	9.35e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.36e-06	9.35e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.36e-06	9.35e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.36e-06	9.33e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.35e-06	9.31e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—pancreatic cancer	1.33e-06	9.13e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—pancreatic cancer	1.33e-06	9.13e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—pancreatic cancer	1.32e-06	9.04e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—pancreatic cancer	1.32e-06	9.04e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—pancreatic cancer	1.3e-06	8.94e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.29e-06	8.85e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.28e-06	8.77e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	8.76e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	1.26e-06	8.65e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—pancreatic cancer	1.26e-06	8.65e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—pancreatic cancer	1.26e-06	8.65e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.2e-06	8.25e-06	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—pancreatic cancer	1.19e-06	8.16e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—pancreatic cancer	1.15e-06	7.89e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.11e-06	7.65e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—pancreatic cancer	1.11e-06	7.63e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—pancreatic cancer	1.11e-06	7.63e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.04e-06	7.15e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.02e-06	6.99e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	9.81e-07	6.74e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—pancreatic cancer	8.31e-07	5.71e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.85e-07	5.39e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.41e-07	4.41e-06	CbGpPWpGaD
